Blogs
Massive Volume Surge in Botanix Pharmaceuticals (ASX: BOT): Is it finally finding a bottom?
Botanix Pharmaceuticals has seen a sharp volume spike after a major share price decline, hinting at possible bottoming. While Sofdra sales are growing and funding has improved liquidity, the stock remains in a downtrend, with any recovery dependent on stronger fundamentals and a break above key resistance.
Is Qantas Airways (ASX: QAN) a buy opportunity after the recent drop or a falling knife?
Qantas (ASX: QAN) has pulled back sharply in 2026, but the decline is largely driven by cyclical pressures rather than a broken business. The key trigger has been a surge in jet fuel costs, which have more than doubled in recent months.
How much higher can the breakout in Liontown's (ASX: LTR) share price take it?
Liontown Resources has rallied on stronger lithium prices, improving production at Kathleen Valley, and a healthier balance sheet after reducing debt. Rising EV and battery demand plus new offtake deals have lifted sentiment. The stock is now approaching key resistance around A$2.20, where the next breakout or pullback will likely be decided.
Invictus Energy (ASX: IVZ): Billion-Barrel Potential or Bust?
Invictus Energy is an early-stage oil and gas explorer in Zimbabwe with large but unproven resource potential. With no revenue and heavy funding needs, the stock offers significant upside if discoveries succeed, but remains a high-risk, news-driven investment.
CETTIRE's (ASX: CTT) share price is back to all time low levels, is it time to buy?
Recent tariff changes and trade frictions have disrupted that advantage and slowed growth. However, CETTIRE’s flexible, low-cost structure suggests its core model remains intact, leaving the company with meaningful long-term profit potential despite the current uncertainty around customer growth and demand.
Rising fuel costs are accelerating EV sales, and these ASX lithium stocks stand to gain the most.
Rising fuel costs are speeding up EV adoption, with global sales surpassing 20 million in 2025 and now over 20% of new car sales. This directly boosts lithium demand, positioning ASX lithium stocks to benefit from both EV growth and pricing cycles.
Coal prices are rallying amid the ongoing energy crisis. How to get exposure on the ASX?
Coal prices are rising as global energy disruptions, particularly gas supply issues linked to Middle East tensions, push utilities to switch to coal as a reliable fallback fuel. Strong electricity demand in Asia and limited short-term alternatives are further supporting demand. Australian coal producers are well positioned to benefit, with higher prices boosting margins and cash flow, making ASX-listed coal stocks a direct way to gain exposure to this trend.
LaserBond (ASX: LBL): Undervalued Industrial Compounder Ready to Re-Rating?
LaserBond (ASX: LBL) is a niche industrial tech company that extends the life of heavy equipment for sectors like mining and energy. It delivers strong margins and cash flow, with growth driven by acquisitions, OEM partnerships, and rising demand for refurbishment solutions. The stock trades on reasonable valuations with a dividend, offering upside if growth and momentum continue.
Is 4DMedical (ASX: 4DX) the Next High-Growth MedTech Breakout or a Funding Risk?
4DMedical Limited is an Australian medtech company developing lung imaging software that turns standard scans into functional insights. It has strong growth potential through scalable products like CT:VQ, but remains speculative due to ongoing cash burn, reliance on adoption, and funding risk.
Which ASX cybersecurity stocks are best positioned to benefit from the surge in cyber spending?
Rising cyber threats, stricter regulations, and the rapid shift to cloud and AI systems are driving a sharp increase in global cybersecurity spending, and the ASX is starting to reflect that trend. The Australian cybersecurity market alone is expected to grow from about A$8.4 billion in 2025 to nearly A$19.6 billion by 2030, highlighting the scale of opportunity ahead.
Acrow Limited (ASX: ACF): Is This Growing Equipment Rental Business a Buy in Oversold Territory?
Acrow Limited is an Australian engineering and equipment rental company supplying formwork and scaffolding to construction and infrastructure projects. The business generates recurring income from its large hire fleet and has delivered strong revenue growth in recent years. Despite recent share price weakness, it offers solid cash flow and a fully franked dividend yield above 5%.
New Murchison Gold (ASX: NMG): Pay for the Current Gold, Get the Exploration Potential for Free
New Murchison Gold Limited is a small Australian gold producer operating the Crown Prince mine in Western Australia. The company recently transitioned from exploration to production and is generating strong cash flow from high-grade ore sold to Westgold Resources Limited. Exploration at nearby targets and potential underground mining could extend the project’s life and add future growth potential.
These ASX stocks give you exposure to the rising interest in defence spending
Rising geopolitical tensions and military modernisation are driving a surge in global defence spending, which exceeded US$2.6 trillion in 2025. Australia is also increasing defence investment, with spending expected to approach A$100 billion by 2034. As a result, ASX-listed companies involved in defence technology, shipbuilding and security systems are gaining investor attention as part of a long-term growth trend.
Electro Optic Systems (ASX: EOS): Pricing the Counter-Drone and Laser Defence Opportunity
Electro Optic Systems develops remote weapon systems, counter-drone platforms and laser defence technologies for military customers. Despite strong order-book growth and rising defence demand, the company still generates operating losses and negative cash flow. Its valuation is largely based on future growth in counter-drone and directed-energy defence systems.
Racura Oncology Ltd (ASX: RAC): Could RC220 Turn This Small Biotech into a Billion-Dollar Cancer Stock?
Racura Oncology is a clinical-stage biotech developing RC220 (bisantrene), a potential treatment for cancers such as AML and lung cancer. The company is pre-revenue and mainly funded through cash reserves and capital raises while advancing clinical trials. Its future valuation depends largely on trial results, regulatory progress and potential partnerships if the drug proves effective.
Has Telix Pharmaceutical's (ASX: TLX) share price reached the bottom?
Telix Pharmaceuticals is a radiopharmaceutical company focused on cancer imaging and therapies, with strong revenue growth driven by products like Illuccix and Gozellix. While recent gains suggest the stock may be stabilising, future performance will depend on continued commercial growth and pipeline progress.
How much higher can Lynas Rare Earths (ASX: LYC) share price go?
Lynas Rare Earths is the largest rare earth producer outside China, supplying critical magnet materials used in EVs, renewable energy and defence technologies. Its core Mt Weld mine and expanding processing facilities position the company as a key player in the Western rare earth supply chain. While earnings remain highly sensitive to rare earth prices, ongoing capacity expansion and stronger NdPr demand could support significant long-term growth.
Is it a good time to buy NRW Holdings (ASX: NWH) after the bounce off its major support level?
NRW Holdings is an Australian mining services contractor providing civil construction and contract mining to major producers like BHP and Rio Tinto. Its earnings are closely tied to Australia’s mining investment cycle. Strong cash flow and new contracts could support recovery if resource sector capex remains strong.
Mineral Resources (ASX: MIN): An undervalued ASX miner facing an important resistance level
Mineral Resources is emerging from a heavy investment phase as the Onslow Iron project reaches scale, driving a sharp recovery in earnings and cash flow. With iron ore production ramped up and lithium assets backed by a major POSCO partnership, the business is now showing the financial benefits of years of expansion. Despite the turnaround, the stock still appears undervalued relative to its long‑term earnings, cash‑flow potential, and asset base.
Which companies on the ASX will benefit the most from the soaring oil and gas prices?
Geopolitical tensions and supply disruptions have pushed global oil and gas prices higher. When benchmarks rise, ASX energy producers—especially upstream and LNG exporters—often see stronger revenues and margins due to robust demand from Asian markets.
TechnologyOne (ASX: TNE): A Defensive SaaS Compounder with Premium Valuation
TechnologyOne is a leading Australian SaaS provider delivering cloud ERP software to governments and large organisations. Its recurring revenue model supports strong margins and steady growth. However, the stock trades at a premium valuation, leaving little margin for growth disappointments.